Hayati Yarkadas - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: EVP & President, WI
Issuer ticker: XYL
Reported as of: 01 Mar 2026
Net transaction value: +$2,543,873
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:44:09 UTC
Prior SEC filing: 06 Mar 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for Hayati Yarkadas

Key filing fact

Hayati Yarkadas filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.

Key facts

This page summarizes Hayati Yarkadas's Form 4 filing for Xylem Inc. (XYL).
9 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:44.

Change

Previous filing in this sequence was filed on 06 Mar 2025.
Current net transaction value: +$2,543,873.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001657363 Primary reporting owner

Yarkadas Hayati

Relationship: EVP & President, WI
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Mike Nazario, by power of attorney for Hayati Yarkadas
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $574,735
Shares: +4,456
Change %: +23%
Price: $128.98
Shares after: 24,142
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1, F2

XYL transaction

Common Stock

Award

Transaction value: $474,517
Shares: +3,679
Change %: +15%
Price: $128.98
Shares after: 27,821
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F3

XYL transaction

Common Stock

Award

Transaction value: $322,579
Shares: +2,501
Change %: +9%
Price: $128.98
Shares after: 30,322
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F4

XYL transaction

Common Stock

Award

Transaction value: $227,134
Shares: +1,761
Change %: +5.8%
Price: $128.98
Shares after: 32,083
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F5

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +2,274
Change %: +7.1%
Price: $0.000000
Shares after: 34,357
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F6

XYL transaction

Common Stock

Tax liability

Transaction value: $72,874
Shares: -565
Change %: -1.6%
Price: $128.98
Shares after: 33,792
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F7

XYL transaction

Common Stock

Tax liability

Transaction value: $12,124
Shares: -94
Change %: -0.28%
Price: $128.98
Shares after: 33,698
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F8

XYL transaction

Common Stock

Tax liability

Transaction value: $15,091
Shares: -117
Change %: -0.35%
Price: $128.98
Shares after: 33,581
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F9

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Award

Transaction value: $1,044,996
Shares: +8,102
Change %
Price: $128.98
Shares after: 8,102
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,102
Exercise price: $128.98
Footnotes: F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Reflects the acquisition of 4,456 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

Footnote F2

Includes additional shares due to dividend reinvestment.

Footnote F3

Reflects the acquisition of 3,679 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.

Footnote F4

Reflects the acquisition of 2,501 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.

Footnote F5

Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.

Footnote F6

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

Footnote F7

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).

Footnote F8

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

Footnote F9

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (75) and March 1, 2024 (42) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F10

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.